You are here: Industry Insights > IPO

News List

Nuvalent Announces Closing of Upsized Initial Public Offering firstwordpharma
August 03, 2021
Nuvalent, Inc. today announced the closing of its upsized initial public offering of 11,212,500 shares of common stock, consisting of 10,612,500 shares of Class A common stock and 600,000 shares of Class B common stock
MiNK Therapeutics Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering firstwordpharma
July 29, 2021
MiNK Therapeutics today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock.
Vaccine biotech Icosavax sets terms for $150 million IPO firstwordpharma
July 23, 2021
Icosavax plans to raise $150 million in its initial public offering by offering 10 million shares at a price range of $14 to $16, as reported by NASDAQ.
Rare disease biotech Rallybio sets terms for $81 million IPO firstwordpharma
July 23, 2021
Rallybio plans to raise $81 million in its initial public offering by offering 5.8 million shares at a price range of $13 to $15, as reported by NASDAQ.
Imago BioSciences, Inc. Announces Closing of $134.4 Million Initial Public Offering firstwordpharma
July 21, 2021
Imago BioSciences, Inc. today announced the closing of $134.4 million in gross proceeds from its previously announced initial public offering and $20.0 million in gross proceeds from its concurrent private placement.
Cancer Research UK reports ‘most successful financial year’ for its spinouts pharmatimes
July 16, 2021
Cancer Research UK (CRUK) has reported record levels of investment for its spinout portfolio, with the ‘most successful financial year’ recorded to date.
Immunotherapy biotech HCW Biologics sets terms for $50 million IPO firstwordpharma
July 08, 2021
HCW Biologics announced terms for its IPO on Wednesday, saying it plans to raise $50 million by offering 5.6 million shares at a price range of $8 to $10, reported Renaissance Capital.
Rare disease biotech Rallybio files for a $100 million IPO firstwordpharma
July 06, 2021
Rallybio has filed with the SEC to raise up to $100 million in an initial public offering, reported Renaissance Capital.
Dermatology biotech Dermata Therapeutics sets terms for $15 million IPO firstwordpharma
July 05, 2021
Dermata Therapeutics plans to raise $15 million in its initial public offering of 1.9 million shares at a price range of $7 to $9, Renaissance Capital reported.
Caribou Biosciences Files up to $100M IPO firstwordpharma
July 02, 2021
Caribou Biosciences has filed for an initial public offering of $100 million, reported StreetInsider.

Previous page 1 2 3 4 5 6 7 8 9 Next page